Study provides valuable insights into the DCB-only strategy for left main coronary artery disease

Sanna Uskela et al., at North Karelia Central Hospital-Heart Center, Finland, conducted a retrospective single-center registry study that focused on the use of drug-coated balloon (DCB)-only strategy for treating de novo left main coronary artery disease.

Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): Half Year Results Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA 14.08.2024 / 19:15 CET/CEST

August 15, 2024

Struggling bluebird bio to go private for less than $30m – Pharmaceutical Technology

Bluebird bio has found a new nest with Carlyle and SK Capital. Credit: pchoui via Getty Images. Bluebird bio will be acquired by investment firms

February 21, 2025

Researchers elucidate how gene mutation mechanism causes autism

Researchers show how mutations of gene transcription and chromatin regulation-related genes cause autism.

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.